2011

According to news sources, the Food and Drug Administration has just given approval to InfraScan Inc. of Philadelphia to begin marketing the first non invasive hand-held device to be utilized in detecting bleeding skulls. The device, named the Infrascanner Model 1000, uses near-infrared spectroscopy to help identify bleeding in the skull. Health care providers will… read more

According to news sources, the Food and Drug Administration is taking a closer look at the arsenic levels found in juices and juice concentrates to ensure compliance with existing safety standards. The FDA has been monitoring the levels of arsenic found in juices sold nationwide for more than 20 years and is currently taking additional… read more

According to news sources, safety concerns regarding the drug Pradaxa have led The Food and Drug Administration to caution healthcare providers about the safety of the drug after a large scale clinical trial found “serious bleeding events” related to the drug. The FDA is currently in the process of attempting to identify if the drug… read more

According to news sources, the Food and Drug Administration has announced that they will be considering additional safety measures such as potentially ordering new warning labels for newer birth control drugs after ongoing research suggested that the newer drugs were more likely to cause blood clots than older birth control drugs. The FDA will meet… read more

The Food and Drug Administration has announced a safety review of the drug ondansetron, an anti-nausea medication, often prescribed to patients of chemotherapy, radiation therapy, and those who have undergone recent surgery. Studies indicate that ondansetron can increase the chances of prolongation of the QT interval of the electrocardiogram, which can lead to irregular heart… read more